We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Cormedix Inc
8 own
20 watching
Current Price
$5.14
$0.02
(0.39%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
220.07M
52-Week High
8.025
52-Week Low
2.645
Average Volume
0.44M
Dividend Yield
--
P/E Ratio
--
Market Capitalization220.07M52-Week High8.02552-Week Low2.645Average Volume0.44MDividend Yield--P/E Ratio--What does the Cormedix Inc do?
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Read More
How much money does Cormedix Inc make?
News & Events about Cormedix Inc.
Globe Newswire
1month ago
BERKELEY HEIGHTS, N.J., May 01, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced that the United States ...
Benzinga
2 months ago
Latest Ratings for CRMD
DateFirmActionFromTo May 2021NeedhamMaintainsBuy Feb 2021NeedhamInitiates Coverage OnBuy Feb 2021Truist SecuritiesMaintainsBuy
View More Analyst Ratings for CRMD
View the Latest Analyst Ratings
read more...
Globe Newswire
2 months ago
BERKELEY HEIGHTS, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced that it will report its ...
Zolmax
3 months ago
Needham Company LLC reissued their buy rating on shares of CorMedix (NASDAQ:CRMD Get Rating) in a research report report published on Friday morning, Benzinga reports. Needham Company LLC currently has a $13.00 price target on the stock. Separately, JMP Securities lifted their ...
Globe Newswire
4 months ago
BERKELEY HEIGHTS, N.J., Jan. 17, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced the following promotions ...
Frequently Asked Questions
Frequently Asked Questions
What is Cormedix Inc share price today?
Can Indians buy Cormedix Inc shares?
How can I buy Cormedix Inc shares from India?
Can Fractional shares of Cormedix Inc be purchased?
What are the documents required to start investing in Cormedix Inc stocks?
What is today’s traded volume of Cormedix Inc?
What is today’s market capitalisation of Cormedix Inc?
What is the 52-Week High and Low Range of Cormedix Inc?
What percentage is Cormedix Inc down from its 52-Week High?
What percentage is Cormedix Inc up from its 52-Week Low?
Current Price
$5.14
$0.02
(0.39%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.